AIRLINK 172.90 Decreased By ▼ -2.83 (-1.61%)
BOP 13.22 Increased By ▲ 0.10 (0.76%)
CNERGY 7.42 Decreased By ▼ -0.12 (-1.59%)
FCCL 43.40 Decreased By ▼ -0.51 (-1.16%)
FFL 14.91 Decreased By ▼ -0.10 (-0.67%)
FLYNG 26.50 Decreased By ▼ -0.40 (-1.49%)
HUBC 129.41 Decreased By ▼ -0.82 (-0.63%)
HUMNL 13.30 Decreased By ▼ -0.04 (-0.3%)
KEL 4.45 Decreased By ▼ -0.05 (-1.11%)
KOSM 6.00 Decreased By ▼ -0.06 (-0.99%)
MLCF 55.40 Decreased By ▼ -0.63 (-1.12%)
OGDC 213.22 Decreased By ▼ -1.55 (-0.72%)
PACE 5.89 Decreased By ▼ -0.09 (-1.51%)
PAEL 41.15 Increased By ▲ 0.25 (0.61%)
PIAHCLA 16.61 Increased By ▲ 0.29 (1.78%)
PIBTL 9.58 Decreased By ▼ -0.17 (-1.74%)
POWER 11.54 Decreased By ▼ -0.22 (-1.87%)
PPL 179.00 Decreased By ▼ -2.48 (-1.37%)
PRL 33.70 Decreased By ▼ -0.52 (-1.52%)
PTC 22.85 Decreased By ▼ -0.21 (-0.91%)
SEARL 94.20 Decreased By ▼ -1.52 (-1.59%)
SILK 1.18 Increased By ▲ 0.04 (3.51%)
SSGC 35.00 Decreased By ▼ -0.45 (-1.27%)
SYM 15.79 Increased By ▲ 0.04 (0.25%)
TELE 7.83 Decreased By ▼ -0.04 (-0.51%)
TPLP 10.83 Decreased By ▼ -0.15 (-1.37%)
TRG 60.79 Increased By ▲ 0.29 (0.48%)
WAVESAPP 10.69 Decreased By ▼ -0.12 (-1.11%)
WTL 1.33 Decreased By ▼ -0.02 (-1.48%)
YOUW 3.80 Increased By ▲ 0.03 (0.8%)
BR100 12,052 Decreased By -1.3 (-0.01%)
BR30 36,449 Decreased By -17.8 (-0.05%)
KSE100 113,886 Decreased By -470.1 (-0.41%)
KSE30 35,113 Decreased By -234.1 (-0.66%)

NEW DELHI: India’s government laboratories should give “top priority” to testing cough syrup for export, the drug regulator said on Wednesday, after the deaths of dozens of children in Gambia and Uzbekistan were linked to the medicines.

The Central Drugs Standard Control Organisation’s directive also said laboratories should issue test reports immediately, or as early as possible, after analysing samples from manufacturers.

India made tests for cough syrup exports mandatory earlier this week after the World Health Organization (WHO) found toxins in cough syrups made by three Indian companies.

India makes tests mandatory for cough syrup export after overseas deaths

Syrups made by two of these companies were linked to the deaths of 70 children in Gambia and 19 in Uzbekistan last year.

The deaths shook the reputation of India’s $41 billion pharmaceutical industry, one of the world’s largest, and the government is considering an overhaul of its pharmaceutical industry policy to tighten procedures on testing and raw materials.

India considers policy change after cough syrup deaths

The Wednesday directive was sent to all federal government laboratories and to drug regulators in six major production states and one federal territory.

From June 1, all cough syrup exported from India will need a certificate of analysis from a government laboratory. The Health Ministry has not responded to requests for comment from Reuters on whether such tests would also be required for the domestic market.

Gambian doctors’ fight to ban toxic Indian syrup

Indian tests of cough syrups made by Maiden Pharmaceuticals Ltd, linked to the deaths of children in Gambia, found no toxins but contaminants were detected in many drugs made by Marion Biotech, whose syrups were linked to deaths in Uzbekistan. The companies deny any wrongdoing.

Comments

Comments are closed.